miRNA miR-590-3p, which has been proved to play an active role in inflammation (47), could directly target NLRP1 and NOX4 and inhibit pyroptosis in diabetic retinopathy through the NOX4/ROS/TXNIP/NLRP3 pathway (42). This evidence concerns the gene NOX4 and diabetic retinopathy.